Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome
NCT06560294Recruiting
- Sponsor
- Tanta University
- Start
- Aug 2024
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Tanta University. Primary endpoint: Degree of pain at 3 months. Started Aug 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06560294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06560294.